PE-22-28 10mg

Research Studies: Selective TREK-1 potassium channel antagonist for investigating antidepressant-like signaling pathways Facilitates analysis of hippocampal brain-derived neurotrophic factor expression and activation Supports research on glutamatergic neurotransmission modulation and synaptic plasticity in assays Enables evaluation of rapid-acting neurogenic responses within controlled cellular assay models